ENTERASENSE LIMITED
Desconocido
eCAP: eCAP - Ehealth CAPsule for digestive disease diagnostics and therapy
ENTERASENSE LIMITED
participó en un
HORIZON EUROPE:
HORIZON-HLTH-2021-TOOL-06
ECAP aims to deliver a novel medical device which combines a smart capsule with an e-health platform for better diagnostics, patient empower...
2022-05-20 - 2026-04-30 | Financiado
2022-05-20 - 2026-04-30 | Financiado
PillSense: Accelerating market introduction of the first real time diagnistic and monitoring device for upper g...
ENTERASENSE LIMITED
tramitó un
H2020:
H2020-EIC-FTI-2018-2020
Upper gastrointestinal bleeding (UGIB) is a potentially life-threatening condition that affects approx. 2 million people annually in Europe...
2018-12-07 - 2021-06-30 | Financiado
2018-12-07 - 2021-06-30 | Financiado
* No se disponen de datos de la empresa actual.